CompaniesCARGO Therapeutics

CARGO Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

101

By Phase

PHASE2: 1

By Status

TERMINATED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05972720Lead Sponsor

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

PHASE2Terminated

101 participants

Started: Aug 1, 2023 · Completed: Apr 4, 2025

Funding History (20)

8-K

Aug 19, 2025

8-K

Jul 8, 2025

8-K

Jul 2, 2025

8-K

Jun 20, 2025

DEFA14A

Apr 29, 2025

DEF 14A

Apr 29, 2025

8-K

Mar 18, 2025

8-K

Feb 24, 2025

8-K

Jan 29, 2025

8-K

Jan 10, 2025

Related Companies

Concentra Biosciences

acquired